Keywords: gsk, darapladib, prevents, necrotic, core, expansion, uk

GSK's darapladib prevents necrotic core expansion

Article | 08 September 2008

Print This

UK drug major GlaxoSmithKline says that results of the IBIS-2 study showed that use of the selective lipoprotein-associated phospholipase A2 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in